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There is now ample evidence of close interactions between the central nervous 
system and the immune system. Neurohormones and neurotransmitters play an 
important role in immunomodulation. Similarly, products of the immune system 
contribute to neuroendocrine secretion and may also possess specific behavioral 
properties. Animal studies have shown that stress can interfere with immune 
regulation and mediate the release of interleukins. Human studies assessing 
interactions between stress and immunity have been relatively scarce. We have 
reported earlier that patients suffering from a major depression show a decrease in 
natural killer (NK) cell activity.' We have also shown that electroconvulsive therapy 
(ECT), an effective and well known treatment for depression, increases NK cytotox- 
icity.2 We therefore formulated the hypothesis that ECT will also be accompanied 
by an increase in plasma levels of interleukin-6 (IL-6). 
Eight hospitalized psychiatric patients who were suffering from affective disor- 
ders and who were referred to the ECT service by their attending physicians were 
included in the study. Their mean age was 48.9 yr (range = 17 to 82 yr). Four patients 
were male, four were female. The purpose of the study was explained to each subject 
and an informed consent was obtained. Venous blood samples were drawn from a 
previously inserted forearm catheter at two time points in relation to the first E C T  
immediately before ECT treatment and 10 min after ECT. The blood samples were 
centrifuged immediately after drawing and the plasma was frozen and kept at -70" 
C. The frozen samples were later thawed and IL-6 activity was measured using the 
IL-6-dependent B-9 hybridoma cell line kindly provided by Dr. Lucien Aarden. One 
hundred pl of 1: lO diluted plasma sample was combined with 5000 B9 cells in 100 pl 
IMDM/S% FCS in flat-bottom microtiter plates for a final volume of 200 ,ul. All 
samples were run in duplicate. The control medium, which contained no IL-6, was 
run in quadruplicate. In addition to the undiluted plasma samples, a serial dilution 
of each sample was assayed. Cells were pulsed at 68 to 72 h with 0.5 pCi 
[3H]thymidine, harvested onto glass fiber filter strips, and the radioactivity incorpo- 
rated into DNA was counted by a pscintillation counter. For each assay, a standard 
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curve was run with recombinant human IL-6. One unit of IL-6 is equal to the amount 
that caused half-maximum proliferation in the standard curve. From this standard 
curve, a best-fit regression was calculated for the rising portion of the curve in the 
linear range. The equation for this best fit line was used to calculate IL-6 activity in 
plasma samples. 
Concentrations of IL-6 before and after ECT are shown in FIGURE 1. Levels of 
IL-6 before ECT showed a wide range of variation (mean=130.6 U/ml, range 39.5 to 
552.0 U/ml). Similarly, IL-6 levels after ECT also showed a wide range (mean=372.1 
































FIGURE 1. Plasma concentrations of interleukin-6 (IL6) immediately before and lOmin after 
electroconvulsive therapy (ECT). The values after ECT were higher than corresponding pre- 
ECT values in seven of the eight patients studied. 
Ulml; range=41.5 to 2,371.0 U/ml). However, as FIGURE 1 shows, in seven of the 
eight patients studied, the IL-6 levels after ECTwere higher than the corresponding 
pre-ECTvalues. These results were statistically significant using the non-parametric 
sign test (X=l, n=8, p=0.035, one-tail). 
The mechanisms leading to the increase in plasma levels of IL-6 following ECT 
are not clear. It is possible that this increase in IL-6 may be the result of an increase 
in IL-1. IL-1 irnmunoreactivity has been demonstrated in brain cells.3 Furthermore, 
IL-1 has been shown to increase the secretion of hormones such as ACTH and 
cortisol, which are also increased following ECT: It is also possible that ECT 
stimulates the release of IL-6 directly. Preliminary evidence suggests that IL-6 can 
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be  secreted by hypothalamic neurons in virro, particularly in  the presence of 
lipopolysaccharide (LPS).5 The  secretion of JL-6 has also been shown t o  increase in 
vivo following certain forms of stress: Whatever the mechanisms involved, our 
results showing a n  increase in plasma levels of IL-6 following ECT provide yet 
another example of close interactions between the brain and the immune system. 
T h e  clinical implications of these findings remain t o  be  determined. 
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